Navigation Links
A better way to diagnose pneumonia
Date:2/18/2011

Researchers from the Georgia Institute of Technology have created a new sampling device that could prevent thousands of people worldwide from dying of pneumonia each year.

Called PneumoniaCheck, the device created at Georgia Tech is a solution to the problem of diagnosing pneumonia, which is a major initiative of the U.S. Centers for Disease Control and Prevention (CDC).

Pneumonia, an inflammation of the lungs, kills about 2.4 million people each year. The problem is particularly devastating in Africa, Southeast Asia and the Eastern Mediterranean, where a child dies of pneumonia every 15 seconds.

Developed by mechanical engineering students, graduate business students and faculty at Georgia Tech, PneumoniaCheck will be commercially launched this month to healthcare professionals through the startup company, MD Innovate Inc.

"Georgia Tech created a simple and new device to detect the lung pathogens causing pneumonia, " said David Ku, Georgia Tech Regents' Professor of Mechanical Engineering, Lawrence P. Huang Chair Professor for Engineering Entrepreneurship in the College of Management, and Professor of Surgery at Emory University. "It has the potential to save more lives than any other medical device."

Last year, Ku was asked by the head of virology at the CDC to develop a quick and economical way to diagnose pneumonia, particularly in developing nations where it is a leading cause of death among children.

Ku challenged a group of mechanical engineering and bioengineering graduate students to develop an accurate device for diagnosing pneumonia. Current sampling methods using the mouth and nose are only 40 percent effective. The samples are typically contaminated by bacteria in the mouth, which leads to misdiagnosis and an incorrect prescription of antibiotics.

In developing nations, many children with respiratory infections fail to receive adequate care, and the overuse of antibiotics has led to an increase in drug-resistant bacteria. An accurate, easy-to-use and widely available new diagnostic test could improve identification of bacterial respiratory infection in children, reducing the inappropriate use of antibiotics and the long-term negative impacts of drug resistance, according to a recent article in Nature titled "Reducing the global burden of acute lower respiratory infections in children: The contributions of new diagnostics."

As a Tech graduate student, Tamera Scholz and her peers developed the solution PneumoniaCheck.

The device contains a plastic tube with a mouthpiece. A patient coughs into the device to fill up a balloon-like upper airway reservoir before the lung aerosols go into a filter. Using fluid mechanics, PneumoniaCheck separates the upper airway particles of the mouth from the lower airway particles coming from the lungs.

"It's interesting because it's so simple," said Scholz (M.S. '10 Mechanical Engineering), who is now an engineer for Newell Rubbermaid. "It's not a fancy contraption. It's a device that patients cough into and through fluid mechanics it separates upper and lower airway aerosols. Through each iteration, it got simpler. I like that I will be able to see it make a difference in my lifetime."

Once the device was developed, Taylor Bronikowski and a group of Georgia Tech M.B.A. students from the College of Management started developing a business plan for PneumoniaCheck that starts locally and grows globally. They used the device as a test case to develop a Triple Bottom Line company in India that could result in financial profits, environmental sustainability and social benefits, such as jobs and healthcare.

"Our goal is to provide better medicine at a cost savings to patients and hospitals," Bronikowski said. "We wanted a worldwide solution, so patients in developing nations can afford it."

Bronikowksi, Ku and Sarah Ku formed the startup company, MD Innovate Inc., in 2010 to manufacture the device in large quantities and organize distribution and commercialization. The device is now being used in pneumonia studies at Grady Memorial Hospital in downtown Atlanta and the Atlanta Veterans Administration Medical Center, Ku said.

The FDA has cleared PneumoniaCheck for sale in the U.S. The device is licensed but its patent is pending. The company will start selling PneumoniaCheck in the U.S. in January and it could hit other countries in two years, Ku said.

"It's a great feeling, working on something that has the potential to save thousands of lives," Bronikowski said.

On the horizon, Ku and future Georgia Tech graduate students will be developing a simple and effective method for diagnosing pneumonia in regions without healthcare facilities or basic infrastructure.


'/>"/>

Contact: Liz Klipp
klipp@gatech.edu
404-894-6016
Georgia Institute of Technology
Source:Eurekalert

Related biology news :

1. A loose grip provides better chemotherapy
2. Team looks to the cow rumen for better biofuels enzymes
3. Opposites may attract, but they dont make better parents
4. EU grant for better monitoring of Crohns disease using MRI
5. Biofuel grasslands better for birds than ethanol staple corn, researchers find
6. Children in formal child care have better language skills
7. Food of the gods genome sequence could make finest chocolate better
8. Study: Personal contacts at work help people better understand organ donation
9. Soaring is better than flapping
10. Illinois study: Ginseng just got better -- not as bitter
11. Conference goals include better surgery and better surgeons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology: